| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2020 | Hoevenaar WHM, Janssen A, Quirindongo AI, Ma H, Klaasen SJ, Teixeira A, van Gerwen B, Lansu N, Morsink FHM, Offerhaus GJA, Medema RH, Kops GJPL, Jelluma N. Degree and site of chromosomal instability define its oncogenic potential. Nature Communications. 11: 1501. PMID 32198375 DOI: 10.1038/S41467-020-15279-9 | 0.575 | |||
| 2018 | Janssen A, Colmenares SU, Lee T, Karpen GH. Timely double-strand break repair and pathway choice in pericentromeric heterochromatin depend on the histone demethylase dKDM4A. Genes & Development. PMID 30578303 DOI: 10.1101/Gad.317537.118 | 0.594 | |||
| 2018 | Janssen A, Colmenares SU, Karpen GH. Heterochromatin: Guardian of the Genome. Annual Review of Cell and Developmental Biology. PMID 30044650 DOI: 10.1146/Annurev-Cellbio-100617-062653 | 0.636 | |||
| 2016 | Janssen A, Breuer GA, Brinkman EK, van der Meulen AI, Borden SV, van Steensel B, Bindra RS, LaRocque JR, Karpen GH. A single double-strand break system reveals repair dynamics and mechanisms in heterochromatin and euchromatin. Genes & Development. 30: 1645-57. PMID 27474442 DOI: 10.1101/Gad.283028.116 | 0.618 | |||
| 2015 | Koch A, Maia A, Janssen A, Medema RH. Molecular basis underlying resistance to Mps1/TTK inhibitors. Oncogene. PMID 26364596 DOI: 10.1038/Onc.2015.319 | 0.52 | |||
| 2015 | Maia AR, de Man J, Boon U, Janssen A, Song JY, Omerzu M, Sterrenburg JG, Prinsen MB, Willemsen-Seegers N, de Roos JA, van Doornmalen AM, Uitdehaag JC, Kops GJ, Jonkers J, Buijsman RC, et al. Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 26: 2180-92. PMID 26153498 DOI: 10.1093/Annonc/Mdv293 | 0.545 | |||
| 2014 | Medema R, Maia AR, Janssen A, Koch A, Boon U, Buijsman RC, Zaman GJ, Jonkers J. 6INTHE INTERFACE BETWEEN CANCER NUMERICAL AND STRUCTURAL CHROMOSOMAL INSTABILITY: MECHANISMS ACCELERATING CANCER DIVERSITY. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv4. PMID 28170562 DOI: 10.1093/Annonc/Mdu290.3 | 0.656 | |||
| 2013 | Janssen A, Beerling E, Medema R, van Rheenen J. Intravital FRET imaging of tumor cell viability and mitosis during chemotherapy. Plos One. 8: e64029. PMID 23691140 DOI: 10.1371/Journal.Pone.0064029 | 0.573 | |||
| 2013 | Janssen A, Medema RH. Cancer: Stress mixes chromosomes. Nature. 494: 439-41. PMID 23446415 DOI: 10.1038/494439A | 0.628 | |||
| 2012 | Janssen A, Medema RH. Genetic instability: tipping the balance. Oncogene. 32: 4459-70. PMID 23246960 DOI: 10.1038/Onc.2012.576 | 0.602 | |||
| 2011 | Janssen A, van der Burg M, Szuhai K, Kops GJ, Medema RH. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science (New York, N.Y.). 333: 1895-8. PMID 21960636 DOI: 10.1126/Science.1210214 | 0.626 | |||
| 2011 | Janssen A, Kops GJ, Medema RH. Targeting the mitotic checkpoint to kill tumor cells. Hormones & Cancer. 2: 113-6. PMID 21475725 DOI: 10.1007/S12672-010-0059-X | 0.66 | |||
| 2011 | Janssen A, Medema RH. Entosis: aneuploidy by invasion. Nature Cell Biology. 13: 199-201. PMID 21364569 DOI: 10.1038/Ncb0311-199 | 0.548 | |||
| 2011 | Janssen A, Medema RH. Mitosis as an anti-cancer target. Oncogene. 30: 2799-809. PMID 21339734 DOI: 10.1038/Onc.2011.30 | 0.559 | |||
| 2009 | Janssen A, Kops GJ, Medema RH. Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 19108-13. PMID 19855003 DOI: 10.1073/Pnas.0904343106 | 0.64 | |||
| 2009 | Tanenbaum ME, Macůrek L, Janssen A, Geers EF, Alvarez-Fernández M, Medema RH. Kif15 cooperates with eg5 to promote bipolar spindle assembly. Current Biology : Cb. 19: 1703-11. PMID 19818618 DOI: 10.1016/J.Cub.2009.08.027 | 0.638 | |||
| Show low-probability matches. | |||||